Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CONSEQUENT ALL COMERS Clinical PMCF on Peripheral Arteries Treated With SeQuent® Please OTW Paclitaxel Coated Balloon Catheter in an All Comer Patient Population

NCT02460042 is registered in ClinicalTrials.gov with B. Braun Melsungen AG as lead sponsor.

NCT NCT02460042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02460042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CONSEQUENT ALL COMERS Clinical PMCF on Peripheral Arteries Treated With SeQuent® Please OTW Paclitaxel Coated Balloon Catheter in an All Comer Patient Population
Lead sponsor
B. Braun Melsungen AG
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
November 19, 2025
Enrollment
960 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial occlusive disease